What the agency is buying

by RFPFinder from the notice and attachments; the solicitation governs

The Department of Defense is purchasing Febuxostat tablets in 40MG and 80MG dosages. This is a requirements contract, and offers will be evaluated using an unknown method, potentially including a reverse auction.

Scope

Febuxostat 40MG Tablet – 30 Count
Febuxostat 80MG Tablet – 30 Count

Option years: 4Submission: portalDays to respond: 1

How to get the bid documents

Download the 7 documents below (no portal account needed)
Check the submission requirements in the compliance checklist
Submit by portal before 3:00 PM ET on Oct 15

Documents · 7 items, 7 filesDownload all (zip) · Pro

Start here

Solicitation · SPE2D2-26-R-0012 Febuxostat Solicitation.pdfView
Latest amendment · SF30_SPE2D226R00120001.PDFView

PDF
SF30_SPE2D226R00120002.PDF18 KB · 2 pages
View
PDF
SF30_SPE2D226R00120001.PDF18 KB · 2 pages
View
PDF
SPE2D2-26-R-0012 Febuxostat Solicitation.pdf1.0 MB · 66 pages
View
PDF
b073e56f708845a593758939fe906aba.pdf18 KB · 2 pages
View
PDF
eb914f47fbbf441aa32324552c0d0713.pdf1.0 MB · 66 pages
View
PDF
f93d35ec3ec24bd0bd7642997fe8bded.pdf18 KB · 2 pages
View
PDF
fe2f74e904d4497085e1a24ab1479010.pdf18 KB · 2 pages
View

Open the original listing on SAM.gov

Details

Place of performance: PHILADELPHIA, Pennsylvania
Buyer type: Federal
Notice type: Solicitation
Solicitation no.: SPE2D2-26-R-0012
Category: Supplies & Equipment · beta
NAICS: NAICS 325412 (Pharmaceutical Preparation Manufacturing): 12 open RFPs
Size standard: 1,300 employees SBA table, NAICS 325412
PSC: PSC 6505 (DRUGS AND BIOLOGICALS)
Period of performance: 60 months total (base year + 4 option years) from attachment p.8
Contract type: Requirements from attachment p.7
Local presence: Not required
Amendments: 3, last Oct 13
Contact: Christopher Newman
Office: DEFENSE LOGISTICS AGENCY · DLA TROOP SUPPORT
Email: christopher.newman@dla.mil
Phone: 4457377371

Not stated in the notice: estimated value, quantity, FOB terms. Check the bid documents.

Contact details from the source notice. Contact the buyer only about this solicitation.

Key dates

Tue, Aug 25Posted

Not statedQuestions due

Thu, Oct 15 · 3:00 PM ETResponses due · about 26 hours left Under 14 days

Amendment 1: Tue, Sep 22
Amendment 2: Wed, Sep 23
Amendment 3: Tue, Oct 13

Change log

verified Wed, Oct 14 · 11:00 AM ET

Posted · SolicitationTue, Aug 25 · 7:47 AM ET
Amendment · New version of the notice posted at the sourceTue, Sep 22 · 6:06 AM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 1, 2026 · 3:00 PM ETTue, Sep 22 · 6:06 AM ET
Amendment · New version of the notice posted at the sourceWed, Sep 23 · 9:26 AM ET
Deadline moved · Thu, Oct 1, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETWed, Sep 23 · 9:26 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETWed, Oct 7 · 12:33 AM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETThu, Oct 8 · 12:31 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETThu, Oct 8 · 12:32 AM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETFri, Oct 9 · 12:31 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETFri, Oct 9 · 12:32 AM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETSat, Oct 10 · 12:31 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETSat, Oct 10 · 12:32 AM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETSun, Oct 11 · 12:31 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETSun, Oct 11 · 12:31 AM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETMon, Oct 12 · 12:31 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETMon, Oct 12 · 12:32 AM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETTue, Oct 13 · 12:31 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETTue, Oct 13 · 12:32 AM ET
Amendment · New version of the notice posted at the sourceTue, Oct 13 · 8:00 PM ET
Deadline moved · Thu, Sep 24, 2026 · 3:00 PM ET → Thu, Oct 15, 2026 · 3:00 PM ETWed, Oct 14 · 12:31 AM ET
Deadline moved · Thu, Oct 15, 2026 · 3:00 PM ET → Thu, Sep 24, 2026 · 3:00 PM ETWed, Oct 14 · 12:31 AM ET

Change log starts Oct 5, 2026 (tracking began); earlier amendments at SAM.gov are being pulled in.

Report a problem

Notice as published

Febuxostat Tablets

SPE2D2-26-R-0012 Febuxostat Tablets Solicitation

What this office paid before

USAspending.gov, last 36 months

6 awards matched · tier 1: this contracting office (SPE2D2) + PSC 6505. Most recent:

Jun 29, 2026DMS PHARMACEUTICAL GROUP INCSPE2D226F2903 · DELIVERY ORDER · Defense Logistics Agency · ends Jun 29, 2026

Pro

Pro shows every award with the recipient, amount, period and a link to the award record, plus a CSV export. $39/mo.

Awards updated Sat, Oct 10, 2026 · 12:48 AM ET.

This contracting office

314 other open notices from this office · buys mostly Supplies & Equipment, Transportation, Construction

Similar open RFPs

same PSC 6505

Oct 142027 Southern Hemisphere Influenza VaccineDept of DefensePA Oct 146505--Prednisolone 1% Ophthalmic SolutionDepartment of Veterans AffairsIL Oct 156505--Lab Supplies - Radiopharm Philadelphia VA Medical CenterDepartment of Veterans AffairsPA Oct 156505--Lab Supplies - Radiopharm Philadelphia VA Medical CenterDepartment of Veterans AffairsPA Oct 156505--Prednisolone 1% Ophthalmic SolutionDepartment of Veterans AffairsIL Oct 156505--Notice of Intent to Sole-Source for Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan) and Lutathera (Lutetium Lu 177 Dotatate) for Buffalo VA Medical CenterDepartment of Veterans AffairsNY

Listing collected from SAM.gov. Always confirm requirements in the original solicitation before you bid.